NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Adaptyv Bio

Adaptyv Bio

Private
LausanneHealthcare & Life Scienceshttps://www.adaptyvbio.com/

Last Round

Seed

Sep 25, 2025

Total Funding Raised

$10.85M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Adaptyv Bio is a biotechnology company that develops a next-generation protein engineering foundry integrating artificial intelligence, robotics, and nanofluidics to accelerate the design, synthesis, and testing of novel proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Infrastructure

Keywords

laboratory-as-a-serviceLaaSprotein engineeringcloud laboratoryautomated wet labdrug discoveryhigh-throughput screeningAI-first biotechfoundry-as-a-serviceprotein synthesisbiotech infrastructurelab automationbiofoundryusage-based billingenzyme engineeringwet lab API

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adaptyv Bio Comps

Public and private peers based on sector, stage, and business model.

Adaptyv Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Adaptyv Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 25, 2025
DebtJun 1, 2023
Pre SeedFeb 14, 2022
SeedAug 4, 2021
GrantApr 28, 2021

Key People

Founding team and executive leadership

Julian Englert

Co-Founder And CEO

Founding Team

Adaptyv Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Added Cradle, a biotechnology/AI startup, as a customer.

  • Apr 8, 2026

    Over 50 companies now use the platform for wet lab experiments.

Adaptyv Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Adaptyv Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adaptyv Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range34
Year Founded2021
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.